Editorial: Anticoagulation in cardiovascular diseases: evolving role, unmet needs, and grey areas

Antonino Tuttolomondo; Pasquale Pignatelli; Roberto Pola

doi:10.3389/fcvm.2023.1219033

Editorial: Anticoagulation in cardiovascular diseases: evolving role, unmet needs, and grey areas

Antonino Tuttolomondo
, Pasquale Pignatelli
, Roberto Pola^*

^*Corresponding author

University of Palermo
University of Rome La Sapienza

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	1-3
Number of pages	3
Journal	Frontiers in Cardiovascular Medicine
Volume	10
DOIs	https://doi.org/10.3389/fcvm.2023.1219033
Publication status	Published - 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

anticoagulation
atrial fibrillation
direct oral anticoagulant (DOAC)
heparin
ischemic cardiovascular disease
thrombosis
venous thromboembolism (VTE)
vitamin K antagonist (VKA)

Access to Document

10.3389/fcvm.2023.1219033

Cite this

@article{6e7a1ee7c0ff45a9b05a6c98d2fb3d5b,

title = "Editorial: Anticoagulation in cardiovascular diseases: evolving role, unmet needs, and grey areas",

keywords = "anticoagulation, atrial fibrillation, direct oral anticoagulant (DOAC), heparin, ischemic cardiovascular disease, thrombosis, venous thromboembolism (VTE), vitamin K antagonist (VKA), anticoagulation, atrial fibrillation, direct oral anticoagulant (DOAC), heparin, ischemic cardiovascular disease, thrombosis, venous thromboembolism (VTE), vitamin K antagonist (VKA)",

author = "Antonino Tuttolomondo and Pasquale Pignatelli and Roberto Pola",

year = "2023",

doi = "10.3389/fcvm.2023.1219033",

language = "English",

volume = "10",

pages = "1--3",

journal = "Frontiers in Cardiovascular Medicine",

issn = "2297-055X",

publisher = "Frontiers Media SA",

}

TY - JOUR

T1 - Editorial: Anticoagulation in cardiovascular diseases: evolving role, unmet needs, and grey areas

AU - Tuttolomondo, Antonino

AU - Pignatelli, Pasquale

AU - Pola, Roberto

PY - 2023

Y1 - 2023

KW - anticoagulation

KW - atrial fibrillation

KW - direct oral anticoagulant (DOAC)

KW - heparin

KW - ischemic cardiovascular disease

KW - thrombosis

KW - venous thromboembolism (VTE)

KW - vitamin K antagonist (VKA)

KW - anticoagulation

KW - atrial fibrillation

KW - direct oral anticoagulant (DOAC)

KW - heparin

KW - ischemic cardiovascular disease

KW - thrombosis

KW - venous thromboembolism (VTE)

KW - vitamin K antagonist (VKA)

UR - http://hdl.handle.net/10807/275537

U2 - 10.3389/fcvm.2023.1219033

DO - 10.3389/fcvm.2023.1219033

M3 - Editorial

SN - 2297-055X

VL - 10

SP - 1

EP - 3

JO - Frontiers in Cardiovascular Medicine

JF - Frontiers in Cardiovascular Medicine

ER -

Editorial: Anticoagulation in cardiovascular diseases: evolving role, unmet needs, and grey areas

UN SDGs

Keywords

Access to Document

Other files and links

Cite this